ABC | Volume 111, Nº3, September 2018

Original Article Andrade et al Anticoagulation and dental procedure Arq Bras Cardiol. 2018; 111(3):394-399 This is an open-access article distributed under the terms of the Creative Commons Attribution License 13. Agência Nacional de Vigilância Sanitária (ANVISA). Portal Anvisa. [Acesso em 2018 mar 15]. Disponível em http://portal.anvisa.gov.br/noticias/-/ asset_publisher/FXrpx9qY7FbU/content/medicamentos-para-cancer-e- bleedings-aprovados/219201/pop_up?inheritRedirect=false 14. Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med. 2017;377(5):431-41. 15. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, et al. 2017 ACC Expert consensus decision pathway onmanagement of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J AmColl Cardiol. 2017;70(24):3042-67. 16. Gualandro DM, Yu PC, Caramelli B, Marques AC, Calderaro D, Luciana S. FornariLS,etal.3rdGuidelineforPerioperativeCardiovascularEvaluationofthe Brazilian Society of Cardiology. Arq Bras Cardiol. 2017;109(3 Suppl 1):1-104. 17. Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, et al. Management of dental extraction in patients undergoing anticoagulant treatment. Results froma large, multicentre, prospective, case-control study. Thromb Haemost. 2010;104(5):972-5. 18. Weitz JI, Quinlan DJ, Eikelboom JW. Periprocedural management and approach to bleeding in patients taking dabigatran. Circulation. 2012;126(20):2428-32. 19. van Diermen DE, van der Waal I, Hoogstraten J. Management recommendations for invasive dental treatment in patients using oral antithrombotic medication, including novel oral anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(6):709-16. 20. Cohen HV, Quek SY, Subramanian G, Abbas A. New antiplatelet and anticoagulant drugs. Considerations for dental patient management. J N J Dent Assoc. 2013;84 (1):30-3. 21. Breik O, Cheng A, Sambrook P, Goss A. Protocol in managing oral surgical patients taking dabigatran. Aust Dent J. 2014;59(3):296-301. 22. Costantinides F, Rizzo R, Pascazio L, Maglione M. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications. BMC Oral Health. 2016 Jan 28;16:5. 23. Curto A, Albaladejo A, Alvarado A. Dental management of patients taking novel oral anticoagulants (NOAs): dabigatran. J Clin Exp Dent. 2017;9(2):e289-93. 24. Nathwani S, Wanis C. Novel oral anticoagulants and exodontia: the evidence. Br Dent J. 2017;222(8):623-8. 25. Chinnaswami R, Bagadia RK, Mohan A, Kandaswamy E, Chandrasekaran D. Dentists’ knowledge, attitude and practice in treating patients taking oral antithrombotic medications – a survey. J Clin Diagn Res. 2017;11(1):ZC88-ZC91. 26. Motta RH, Bergamaschi CC, de AndradeNK, Guimaraes CC, Ramacciato JC, Araújo JO, et al. Bleeding risk in patients using oral anticoagulants submitted to surgical procedures in dentistry: a systematic reviewprotocol. BMJ Open. 2017;7(12):e019161. 399